The Capital Partnership
Family officeLondon Β· Late Stage
What they invest in
from 4 of 4 portfolio companiesHealthtech Γ3Medical Devices Γ3Hardware Γ2AI & Machine Learning Γ1Biotech Γ1Robotics Γ1
HQs:United StatesΓ4
Investments Β· 4 tracked
founders shown can be your intro pathBy year:2025 Β· 12023 Β· 12 dated
Atia Vision develops OmniVu, a modular shape-changing dual-optic intraocular lens (IOL) that uses the eye's natural accommodative mechanism to restore near, intermediate, and distance vision for cataract patients.
HardwareHealthtechMedical DevicesCampbell, US
Co-investorsAmed VenturesDelos Capital
Supira Medical develops a next-generation percutaneous ventricular assist device (pVAD) to provide temporary mechanical circulatory support for high-risk patients undergoing coronary interventions and those in cardiogenic shock.
HardwareHealthtechMedical DevicesCampbell, US
Nitin Salunke(President & CEO)inJean Orth(Executive Officer)Mariam Maghribi(Executive Officer, Director)
BoardCasey Gordon(Director)Christopher Shen(Director)Bihua Chen(Director)
Co-investors415 CapitalAmed VenturesNovo HoldingsUnorthodox Ventures
HealthtechCampbell, US
Amr Salahieh(Executive Officer, Director)David Voris(Executive Officer)
BoardMariam Maghribi(Director)Gautam Kainth(Director)Bihua Chen(Director)
Co-investorsAmed VenturesLilly Asia VenturesQatar Investment AuthorityUnorthodox Ventures
Laza Medical develops an AI- and robotics-powered ultrasound imaging system for structural heart, electrophysiology, and diagnostic cardiac procedures, combining real-time 3D heart modeling, procedural guidance, and robotic probe control.
AI & Machine LearningBiotechMedical DevicesRoboticsCampbell, US
Amr Salahieh(Executive Officer, Director, Promoter)Pablo Garcia Kilroy(General Manager)inCasey Gordon(Director)Mariam Maghribi(Executive Officer)David Voris(Executive Officer)
Co-investors415 CapitalPage One VenturesUnorthodox Ventures
Portfolio news
latest coverage across their companiesAkura Medical Β· medtechdive.com Β· Dec 3, 2025
Frequently asked questions
- What stage does The Capital Partnership invest at?
- The Capital Partnership invests at the Late Stage stage.
- What sectors does The Capital Partnership focus on?
- The Capital Partnership focuses on Sector Agnostic.
- Where is The Capital Partnership located?
- The Capital Partnership is headquartered in London, GB.
Similar investors
3TS Capital Partners is a private equity and venture capital investor focused on technology and technology-enabled companies, notably in Central and Eastern Europe.
83North is a global venture capital firm that invests in and helps entrepreneurs build large, category-defining companies, backing startups across multiple stages and sectors.
8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.
Accel is a venture capital firm that partners with exceptional teams, positioning itself as a first partner to founders globally.
AirTree Ventures runs Pathfinders, a free four-week in-person program in Sydney for young builders (high-school graduates up to age 23) to work on a real product, access the AirTree team and founders, and build a peer network.





